Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zosano Pharma

0.5576
+0.0000
Volume:- -
Turnover:- -
Market Cap:2.73M
PE:-0.04
High:0.5576
Open:0.5576
Low:0.5576
Close:0.5576
Loading ...

Company Profile

Company Name:
Zosano Pharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.